Search for: "Lupin Pharmaceuticals"
Results 81 - 100
of 175
Sorted by Relevance
|
Sort by Date
21 Jul 2010, 1:05 am
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation (SmartBrief)… [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
26 Jun 2008, 3:39 am
We reported last month that King Pharmaceuticals filed a citizen petition that could delay final approval of numerous ANDAs for generic versions of Altace (ramipril), which were set to earn final approval on June 7. [read post]
2 Jan 2008, 9:05 pm
Lupin Limited et al Teva Pharmaceutical Industries Ltd. et al v Hetero Drugs Ltd. [read post]
29 Mar 2011, 9:19 pm
General Pharmaceutical, biotechnology and chemical inventions – world protection and exploitation (FDA Law Blog) Gene patents on the high seas: who owns the ocean’s IP? [read post]
25 Jul 2008, 2:11 am
Lupin, Ltd., 499 F.3d 1293, 1301 (Fed. [read post]
7 Feb 2011, 6:53 pm
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
10 May 2010, 10:37 am
Lupin Pharmaceuticals, Inc. [read post]
8 Mar 2013, 2:39 am
HC) and M/s.Maxheal Pharmaceuticals v. [read post]
23 Jun 2011, 11:16 pm
Reddys Laboratories Mylan Pharmaceuticals Teva Aurobindo Pharma Glenmark Generics Lupin Wockhardt These companies and others are now allowed to sell their versions of Levaquin in the United States, which so far has earned $ 1.45 billion for a period of 12 months ending in September, 2010. [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
7 Feb 2013, 1:25 pm
Lupin, Ltd., et al., C.A. [read post]
24 Jan 2020, 10:24 am
Lupin – In November 2019, pharmaceutical manufacturer Lupin Limited and related entities, as well as company executives, agreed to pay $63 million to resolve claims brought by a whistleblower under the Texas Medicaid Fraud Prevention Act that Lupin reported inflated drug prices to the state’s Medicaid program in order to receive excess reimbursements Greenway Health – In February 2019, Greenway Health LLC, an electronic health records vendor,… [read post]
11 Dec 2023, 7:43 am
Lupin Ltd. the Federal Circuit “somewhat controversially” states that: [S]ubstantial noninfringing use in section 271(c) refers to uses that do not infringe the patent in question, not other patents. [read post]
13 May 2010, 4:58 pm
Lupin; Photocure v. [read post]
20 May 2008, 5:33 am
It concerns the patentability of the Beta crystalline form of Imatinib, the active pharmaceutical ingredient in the blockbuster drug Glivec (Gleevec). [read post]
3 Jun 2009, 8:55 pm
The Eastern District of Virginia construed the claims and granted-in-part Lupin's motion for summary judgment of noninfringement, In the Illinois action, Abbott sued Sandoz (and Sandoz GmbH, Teva Pharmaceuticals, Ranbaxy Laboratories, Par Pharmaceutical) for infringement after they wanted to market generic versions of Omnicef. [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
11 Nov 2009, 4:02 am
: Bilski (IP Frontline) US: Next up: Ariad v Lilly rehearing en banc (Patent Docs) Products Ablify (Aripiprazole) - US: Otsuka files patent infringement suit against Teva in response to Para IV challenge (Patent Docs) Boniva (Ibandronic acid) - US: Roche drops two lawsuits in response to Teva cancelling plans to manufacture generic Boniva (The IP Factor) Copaxone (Glatiramer) - US: Teva files amended complaint against Momenta/Sandoz to include infringement of three Copaxone-related patents… [read post]
13 Aug 2012, 1:04 pm
Lupin, the patent owner Shinogi obtained allowance for some but not all of its claims for an extended-release pharmaceutical product. [read post]
